The conserved family of BPI-like/PLUNC proteins are potential mediators of host defence in the respiratory, oro- and nasopharyngeal epithelium

L. Bingle, J. Craven, S. Havard, C. D. Bingle (Sheffield, United Kingdom)

Source: Annual Congress 2003 - Role of airway epithelial cells and secretions in acute and chronic inflammation of the airways
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Bingle, J. Craven, S. Havard, C. D. Bingle (Sheffield, United Kingdom). The conserved family of BPI-like/PLUNC proteins are potential mediators of host defence in the respiratory, oro- and nasopharyngeal epithelium. Eur Respir J 2003; 22: Suppl. 45, 363

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
SPLUNC1, a putative mediator of host defence, is predominantly localised in the mucous gland cells of the upper airways, nose and oral cavity
Source: Eur Respir J 2004; 24: Suppl. 48, 554s
Year: 2004

Makrophages regulate epithelial defence of the respiratory tract
Source: Annual Congress 2008 - Airway cell biology
Year: 2008


Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions
Source: Eur Respir J 2016; 48: 1201-1214
Year: 2016



Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
Source: Eur Respir J 2004; 23: 327-333
Year: 2004



Decreased innate immunity proteins in asthmatic respiratory tract lining fluids
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Distribution of WFDC2/HE4, a putative host defence protein, in the respiratory tract of normal and diseased mice
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013

Impairment of respiratory host defence resulting from cigarette smoke-induced changes in airway epithelial cell differentiation
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



EPs®7630 reduced Rhinovirus bronchial epithelial cell infection and modified host defence systems
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018

Commensal lung microbiota members inhibit activation of the pro-inflammatory NF-?B pathway in three-dimensional lung epithelial cells
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Impact of cellular composition on SARS-CoV-2 infection biology and pathogenesis in primary human airway epithelial cells
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Microbial DNA and RNA induce a host defense reaction of human respiratory epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 207s
Year: 2002

FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells
Source: Annual Congress 2012 - New insights into airway epithelial cell physiology
Year: 2012

Activity of an innate defence regulator peptide to alleviate airway inflammation is mitigated by disruption of its central hydrophobic region
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

Validation of an in vitro tracheal model for the study of innate host defence mechanism in respiratory tract infections
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Expression of MIC-A molecules in bronchial epithelium of humans with and without current bacterial infection
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Whole-transcriptome sequencing reveals heightened inflammation and defective host defence responses in chronic rhinosinusitis with nasal polyps
Source: Eur Respir J, 54 (5) 1900732; 10.1183/13993003.00732-2019
Year: 2019